Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care

被引:4
作者
Del Rivero, Jaydira [1 ]
Mailman, Josh [2 ]
Rabow, Michael W. [3 ]
Chan, Jennifer A. [4 ]
Creed, Sarah [5 ]
Kennecke, Hagen F. [6 ]
Pasieka, Janice [7 ]
Zuar, Jennifer [8 ]
Singh, Simron [9 ]
Fishbein, Lauren [10 ]
机构
[1] NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20814 USA
[2] NorCal CarciNET Community, Oakland, CA USA
[3] Univ Calif San Francisco, Dept Internal Med, Div Palliat Med, San Francisco, CA USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Program Carcinoid & Neuroendocrine Tumors, Boston, MA USA
[5] Harvard Kennedy Sch, Good Shepherd Community Care, Natick, MA USA
[6] Portland Providence Med Ctr, Providence Canc Inst Franz Clin, Portland, OR USA
[7] Univ Calgary, Cumming Sch Med, Dept Surg, Sect Gen Surg, Calgary, AB, Canada
[8] Alpert Med Sch, Dept Internal Med, Div Geriatr & Palliat Med, Providence, RI USA
[9] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[10] Univ Colorado, Dept Med, Dept Biomed Informat, Div Endocrinol Metab & Diabet,Sch Med, Aurora, CO USA
关键词
neuroendocrine tumors; palliative care; hospice care; end of life; management; SOCIETY CONSENSUS GUIDELINES; CARCINOID-SYNDROME; MEDICAL-MANAGEMENT; SURVEILLANCE; DIAGNOSIS; THERAPY; CANCER; BIOTHERAPY; LANREOTIDE; INSULINOMA;
D O I
10.1530/ERC-22-0226
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This serves as a white paper by the North American Neuroendocrine Tumor Society (NANETS) on the practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care. The authors involved in the development of this manuscript represent a multidisciplinary team of patient advocacy, palliative care, and hospice care practitioners, endocrinologist, and oncologists who performed a literature review and provided expert opinion on a series of questions often asked by our patients and patient caregivers affected by this disease. We hope this document serves as a starting point for oncologists, palliative care teams, hospice medical teams, insurers, drug manufacturers, caregivers, and patients to have a frank, well-informed discussion of what a patient needs to maximize the quality of life during a routine, disease-directed care as well as at the end-of-life.
引用
收藏
页数:12
相关论文
共 70 条
  • [1] Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors
    Al-Efraij, Khalid
    Aljama, Mohammed A.
    Kennecke, Hagen Fritz
    [J]. CANCER MEDICINE, 2015, 4 (06): : 864 - 870
  • [2] Anekar AA, 2023, WHO Analgesic Ladder
  • [3] Role of Diet in the Management of Carcinoid Syndrome: Clinical Recommendations for Nutrition in Patients with Neuroendocrine Tumors
    Artale, Salvatore
    Barzaghi, Sabrina
    Grillo, Nunziata
    Maggi, Claudia
    Lepori, Stefano
    Butti, Chiara
    Bovio, Antonella
    Barbarini, Lucia
    Colombo, Andrea
    Zanlorenzi, Laura
    Castiglioni, Elena
    Trojani, Alessandra
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (01): : 2 - 11
  • [4] Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial
    Bakitas, Marie A.
    Tosteson, Tor D.
    Li, Zhigang
    Lyons, Kathleen D.
    Hull, Jay G.
    Li, Zhongze
    Dionne-Odom, J. Nicholas
    Frost, Jennifer
    Dragnev, Konstantin H.
    Hegel, Mark T.
    Azuero, Andres
    Ahles, Tim A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) : 1438 - 1445
  • [5] Carcinoid heart disease
    Bernheim, Alain M.
    Connolly, Heidi M.
    Hobday, Timothy J.
    Abel, Martin D.
    Pellikka, Patricia A.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2007, 49 (06) : 439 - 451
  • [6] Managing malignant biliary obstruction in pancreas cancer: Choosing the appropriate strategy
    Boulay, Brian R.
    Parepally, Mayur
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (28) : 9345 - 9353
  • [7] Niacin (Vitamin B3) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor
    Bouma, Grietje
    van Faassen, Martijn
    Kats-Ugurlu, Gursah
    de Vries, Elisabeth G. E.
    Kema, Ido P.
    Walenkamp, Annemiek M. E.
    [J]. NEUROENDOCRINOLOGY, 2016, 103 (05) : 489 - 494
  • [8] Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS)
    Chan, David L.
    Moody, Lesley
    Segelov, Eva
    Metz, David C.
    Strosberg, Jonathan R.
    Pavlakis, Nick
    Singh, Simron
    [J]. NEUROENDOCRINOLOGY, 2018, 107 (01) : 32 - 41
  • [9] Practice review: Evidence-based and effective management of pain in patients with advanced cancer
    Chapman, Emma J.
    Edwards, Zoe
    Boland, Jason W.
    Maddocks, Matthew
    Fettes, Lucy
    Malia, Catherine
    Mulvey, Matthew R.
    Bennett, Michael I.
    [J]. PALLIATIVE MEDICINE, 2020, 34 (04) : 444 - 453
  • [10] Treatment Delay and Facility Case Volume Are Associated With Survival in Early-Stage Glottic Cancer
    Cheraghlou, Shayan
    Kuo, Phoebe
    Judson, Benjamin L.
    [J]. LARYNGOSCOPE, 2017, 127 (03) : 616 - 622